N-1518 is an adrenergic receptor blocker affecting both α and β receptors, acting as a competitive antagonist on β1 and α1 receptors. While it does not exhibit selectivity for β1 receptors, it shows approximately 20-fold selectivity for α1 receptors. N-1518 induces vasodilation and is a potential subject for hypertension research.